Abstract
Introduction

Poly (ADP-ribose) polymerase (PARP) is a chromatin-bound
enzyme that plays a physiological role in the repair of strand breaks in DNA [1] . PARP locates in the nuclei of cells of various tissues, including the heart and skeletal muscle [2] . The breakage of DNA strands can activate PARP. The activation of PARP initiates an energy-consuming cycle by transferring ADP ribose units from NAD ϩ to nuclear proteins [3, 4] . As a result, the damaged DNA was repaired. However, in many pathophysiological processes, such as inflammation, circulatory collapse and heart ischaemia/reperfusion (I/R) injury, massive amounts of reactive oxygen species, including superoxide anions [5] , hydrogen peroxide and hydroxyl radicals [6] , are generated, which cause the breakage of DNA strands and subsequently hyper-active of PARP.
This process leads to the depletion of the intracellular nicotinamide adenine dinucleotide (NAD ϩ ) and ATP energetic pools which leading to cellular dysfunction and death.
Heart I/R may exacerbate myocardial injury by the release of massive of reactive oxygen and nitrogen species. These reactive oxygen and nitrogen species are able to lead to cell necrosis and apoptosis. PARP has been proposed to play a role in the pathogenesis of heart I/R injury [7, 8] . Poly (ADP-ribose) (PAR) is the active morphous of PARP. Immunohistochemical detection of PAR formation demonstrated that PARP was activated in the reperfusion myocardium [9] . Myocardial reperfusion injuries in vitro or in vivo have been shown to ameliorate by pharmacological inhibitors of PARP [10, 11] , which indicated that the PARP pathway is involved in the pathogenesis of heart I/R injury.
Apoptosis-inducing factor (AIF) is a novel apoptotic factor that induces chromatin condensation and large-scale DNA fragmentation. AIF is a caspase-independent mitochondrial death factor [12] . AIF is strictly confined to mitochondria in normal cells. The most conspicuous feature of AIF in apoptosis is its mitochondrial-nuclear translocation, accompanied by nuclear condensation and large-scale DNA degradation [13] . In oxidantinduced cell, AIF transposes to the nucleus and induces cell death. Studies demonstrated that heart I/R in vivo were associated with the nuclear translocation of AIF [12] . Studies also demonstrated that PARP regulated the translocation of AIF, which contributed to myocardial injury and cardiac dysfunction in heart I/R [14, 15] .
Though many studies have reported that PARP hyper-activation prompted mitochondria dysfunction, which in turn released AIF and subsequently led to cell death [16] , the mechanism by which PARP activation led to mitochondrial dysfunction and released of AIF was largely unknown [17, 18] . Recently, Xu et al. [19] 
Materials and methods
Myocardial ischaemia and reperfusion
Experimental groups
The following experimental groups were studied: (1) 
Determination of myocardial infarct size
At the end of reperfusion, the coronary artery was re-occluded and the heart was perfused with 3 [20] . [21] .
Measurement of cardiac function
To monitor cardiovascular function during the I/R protocol, a fluid-filled cannula was introduced via the carotid artery into the left ventricle. LVDP, maximum rate of left ventricular pressure development (ϩdP/dt) and maximum rate of left ventricular pressure decline (-dP/dt) was measured using a pressure transducer interfaced with a computerized heart performance analysis system (Digi-Med, USA).
Terminal deoxynucleotidyltransferase-mediated dUTP nick end labelling (TUNEL)
Preparation of the mitochondrial and nuclear fractions
Heart mitochondria and nuclear fractions were used to evaluate the activation of AIF by western blot analysis, respectively. They were prepared by differential centrifugation, which was described by Kim GT et al. [12] . Briefly, the ischaemic myocardium of killed rats were removed and cut into small pieces. 
Inhibition of PARP activity reduced myocardial infarct size
As shown in Fig. 2A 
Inhibition of PARP reduced the apoptosis of cells of the heart
Figure 3 showed the TUNEL positive cells. TUNEL positive cells were expressed as a percentage of normal nuclei. No TUNEL positive cells were found in the sham group (n ϭ 8). However, the number of TUNEL positive cells was significantly increased in I/R group (35Ϯ5.3%) (n ϭ 7) and I/RϩDMSO group (37Ϯ2.1%) (n ϭ 7). The TUNEL positive cells were significantly reduced to 20Ϯ4.1% in the I/RϩDPQ group (n ϭ 8) (PϽ0.05 versus I/R group). These data suggest that inhibition of PARP activity reduces cells apoptosis in rat heart I/R injury.
Inhibition of PARP activity reduced the activation of JNK
Western blot analysis was performed to examine whether the activation of JNK in the rat model of myocardial I/R was related with PARP. As shown in Fig. 4A, phospho-JNK increased after reperfusion in non-inhibition of PARP rat. Ischaemia and reperfusioninduced activation of phospho-JNK was significantly attenuated in the inhibition of PARP. These data suggest that JNK may be downstream of PARP activation in rat heart I/R injury.
Inhibition of PARP or JNK activity reduces the AIF translocation
As shown in Fig. 4B [22] , circulatory shock [23] and I/R injury generate free radicals and oxidant species leads to DNA injury and the activation of PARP. In this experiment, western blot analysis showed that PARP increased during the reperfusion (up to 24 hrs) protocol. The results conform to those of other researches' [24] . Our experiment also showed that the peak activation of PARP was at 180 min. of re-perfusion. Several independent studies have confirmed that pharmacological inhibition of PARP [24] [25] [26] significantly reduced the infarct size and improved the cardiac function in I/R injury. In this experiment, we used DPQ to inhibit the activation of PARP. As a result, the infarct size of hearts reduced and the cardiac function was protected. DPQ is a very potent PARP inhibitor [27] . Xu et al. [19] in their experiment also used DPQ to inhibit PARP. The cardiac protection afforded by the PARP inhibitors was due to a selective inhibition of PARP. Though PARP was proposed to play a role in the pathogenesis of heart I/R injury, the precise mechanisms of PARP activation in heart I/R injury were not fully understood. Studies proved that mechanisms of PARP activation in heart I/R injury may involve several aspects. The fundamental pathologic effect of PARP activation is related to the myocardial energy metabolism [3, 4] . In heart I/R injury the hyper-activation of PARP is able to disturb the energy generation process and the mitochondrial function. PARP can also regulate the expression of various proteins and cytokines such as ICAM-1 [28] , AP-1 complex [29] , NF-B [30] , . PARP inhibition or PARP deficiency have been shown to suppress the cytokines expression in vitro or in vivo.
DISCUSSION
In this experiment, we used DPQ to inhibit the activation of PARP in the rat model of myocardial ischaemia and reperfusion in vivo; as a
Fig. 1 Western blot analysis of PAR (A), JNK (B) and AIF (C) in rats' hearts subjected to I/R. PAR and phospho-JNK increased during the I/R protocol. The activation of AIF increased in nuclear fractions
AIF is a 67 kD death promoting protein [32] . In healthy cells it is normally confined to mitochondria. Upon death stimuli, AIF transposes from the mitochondria to the nuclei. As a result, largescale DNA break, and cells die. However, van Empel et al. [33] reported that AIF exerts also cytoprotective effects on myocytes both in vitro and in vivo. They found that AIF has a role of antioxidant in stress-induced cell death and development of heart failure induced by pressure overload. But the precise mechanism for AIF protection in these cells was not known. van Empel presumed that AIF plays a critical role in mitochondrial respiration, by handling of reactive oxygen radicals that are normally released by the respiratory chain. In our study, we found that AIF had a proapoptotic role in rat heart I/R injury. Recent studies demonstrated that AIF transposed from the mitochondria to the nuclei required PARP activity [14, 16] [34] . JNK activation is also an important signaling step leading to cardiac myocytes apoptosis [35] . In vivo studies demonstrated that myocardial ischaemia followed by reperfusion in the heart were able to cause activation of JNK [36, 37] . 
